Acumen Pharmaceuticals, Inc. Common Stock (ABOS)

$2.38 +5.79%

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-12 ESTIMATED

Across 20 earnings reports since Aug 16, 2021, Acumen Pharmaceuticals, Inc. Common Stock (ABOS) has a clear post-earnings pattern. It moves ±6.98% on average after reporting and finishes higher 60.0% of the time. Its largest post-earnings gain was +17.3% (May 09, 2023) and its largest decline was -17.03% (Nov 12, 2024). The next earnings report is predicted for 2026-08-12 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.98%

Positive %

60.0%

Negative %

40.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 12, 2026	☀ PRE	$2.53	$2.60	$2.48	12,397	-3.5%	open_in_new
Mar 26, 2026	☀ PRE	$2.52	$2.75	$2.55	40,284	-2.3%	open_in_new
Nov 12, 2025	☀ PRE	$2.00	$2.00	$1.95	12,010	-1.02%	open_in_new
Aug 12, 2025	☀ PRE	$1.30	$1.31	$1.26	10,890	-10.64%	open_in_new
May 13, 2025	☀ PRE	$0.99	$1.05	$1.05	6,045	+0%	open_in_new
Mar 27, 2025	☀ PRE	$1.18	$1.27	$1.23	16,128	+6.96%	open_in_new
Nov 12, 2024	☀ PRE	$3.11	$3.11	$2.68	10,136	-17.03%	open_in_new
Aug 13, 2024	☀ PRE	$2.60	$2.78	$2.77	3,795	+8.2%	open_in_new
May 14, 2024	☀ PRE	$3.51	$3.73	$3.69	3,143	+10.3%	open_in_new
Mar 26, 2024	☀ PRE	$4.06	$4.21	$3.75	18,195	-11.85%	open_in_new
Nov 13, 2023	☀ PRE	$1.99	$2.07	$2.03	17,888	+6.28%	open_in_new
Aug 08, 2023	☀ PRE	$6.91	$7.18	$6.99	23,012	+0.29%	open_in_new
May 09, 2023	☀ PRE	$4.92	$5.84	$5.73	18,043	+17.3%	open_in_new
Mar 27, 2023	☀ PRE	$3.94	$4.17	$4.17	5,552	+6.24%	open_in_new
Nov 14, 2022	☽ POST	$5.66	$6.48	$6.16	17,511	+3.57%	open_in_new
Aug 15, 2022	☽ POST	$5.34	$5.34	$5.33	592	+5.91%	open_in_new
May 16, 2022	☽ POST	$3.40	$3.42	$3.23	5,593	+12.69%	open_in_new
Mar 28, 2022	☽ POST	$4.92	$4.94	$4.63	10,890	-5.07%	open_in_new
Nov 15, 2021	☀ PRE	$12.85	$13.00	$11.76	2,440	-9.58%	open_in_new
Aug 16, 2021	☽ POST	$15.27	$15.38	$15.26	6,561	+0.92%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.98%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260610	open_in_new SEC.gov
144	20260609	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov

Frequently asked about ABOS earnings

When does Acumen Pharmaceuticals, Inc. Common Stock report earnings next? expand_more

Acumen Pharmaceuticals, Inc. Common Stock (ABOS)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ABOS stock move after earnings? expand_more

Over 20 reports, ABOS has moved an average of ±6.98% the session after earnings, closing higher 60.0% of the time.

What was ABOS's biggest post-earnings move? expand_more

ABOS's largest post-earnings gain on record was +17.3% on May 09, 2023, and its largest decline was -17.03% on Nov 12, 2024.

Where can I find Acumen Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more

All of Acumen Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.